{"id":55563,"date":"2023-04-05T23:06:43","date_gmt":"2023-04-05T21:06:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/"},"modified":"2023-04-05T23:06:43","modified_gmt":"2023-04-05T21:06:43","slug":"apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/","title":{"rendered":"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023"},"content":{"rendered":"
\n

CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX)<\/b> (the \u201cCompany\u201d), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion\u00ae<\/sup>, today announced that financial results for the first quarter of fiscal year 2023 will be released before the market opens on Thursday, May 11th.<\/p>\n

\nManagement will host a conference call at 8:00 a.m. Eastern Time on May 11th to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 877-407-8289 (or 201-689-8341 for international callers) and provide access code 13737575. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company\u2019s website and at:<\/p>\n

\nhttps:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=gfBZBEow<\/a><\/p>\n

\nA telephonic replay will be available approximately two hours through the following two weeks. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13737575. The webcast will be archived on the Investor Relations section of the Company\u2019s website.<\/p>\n

\nAbout Apyx Medical Corporation<\/span>:<\/b><\/p>\n

\nApyx Medical Corporation is an advanced energy technology company with a passion for elevating people\u2019s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma\u00ae in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations<\/span>:<\/b>
ICR Westwicke on behalf of Apyx Medical Corporation
\n
Mike Piccinino, CFA
\n
investor.relations@apyxmedical.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the \u201cCompany\u201d), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion\u00ae, today announced that financial results for the first quarter of fiscal year 2023 will be released before the market opens on Thursday, May 11th. Management will host a conference call at 8:00 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55563","6":"format-standard","7":"category-industry"},"yoast_head":"\nApyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the \u201cCompany\u201d), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion\u00ae, today announced that financial results for the first quarter of fiscal year 2023 will be released before the market opens on Thursday, May 11th. Management will host a conference call at 8:00 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-05T21:06:43+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023\",\"datePublished\":\"2023-04-05T21:06:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/\"},\"wordCount\":336,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/\",\"name\":\"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-04-05T21:06:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/","og_locale":"en_US","og_type":"article","og_title":"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 - Pharma Trend","og_description":"CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the \u201cCompany\u201d), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion\u00ae, today announced that financial results for the first quarter of fiscal year 2023 will be released before the market opens on Thursday, May 11th. Management will host a conference call at 8:00 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-05T21:06:43+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023","datePublished":"2023-04-05T21:06:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/"},"wordCount":336,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/","url":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/","name":"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-04-05T21:06:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2023-financial-results-on-may-11-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55563"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55563\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}